Elanco Animal Health (ELAN) Shares Outstanding (2017 - 2026)

Elanco Animal Health has disclosed Shares Outstanding across 10 years of filings, most recently posting $499.4 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $499.4 million, up 0.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $499.4 million (up 0.58% YoY), and the FY2025 annual result was $497.0 million, up 0.52% from the prior year.
• Shares Outstanding came in at $499.4 million for Q1 2026 at Elanco Animal Health, roughly flat from $497.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $499.4 million in Q1 2026 to a low of $474.1 million in Q1 2022.
• The 5-year median for Shares Outstanding is $494.0 million (2024), against an average of $490.0 million.
• Across the five-year window, Shares Outstanding gained 0.23% in 2022 and advanced 3.92% in 2023, its largest moves.
• Elanco Animal Health's Shares Outstanding stood at $474.2 million in 2022, then advanced by 3.92% to $492.8 million in 2023, then rose by 0.32% to $494.4 million in 2024, then climbed by 0.52% to $497.0 million in 2025, then increased by 0.48% to $499.4 million in 2026.
• The last three Shares Outstanding figures came in at $499.4 million (Q1 2026), $497.0 million (Q4 2025), and $496.8 million (Q3 2025), per Business Quant data.